Lars Ny

Sahlgrenska University Hospital — Sweden

Immunology and Microbiology · Life Sciences

38h-index4.7kcitations268works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(115), Ocular Oncology and Treatments(100), Cancer Immunotherapy and Biomarkers(54), CAR-T cell therapy research(53), Melanoma and MAPK Pathways(36)

Publications267 total

Five-year survival after introduction of adjuvant treatment in stage III melanoma: A nationwide registry-based study
European Journal of Cancer·2025Open Access
Brain metastasis in stage IV lung adenocarcinoma is frequently missed by symptom-based screening
Discover Oncology·2025Open Access
Neoadjuvant immunotherapy for patients with resectable stage III cutaneous melanoma – a comparison between response in lymph node metastasis and in-transit metastasis
European Journal of Surgical Oncology·2025
A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first‐line treatment for patients with melanoma in‐transit metastases
UNC Libraries·2025Open Access
Evaluation of the flipped dose NIVO3+IPI1 in patients with advanced unresectable melanoma
JNCI Journal of the National Cancer Institute·2025· 1 citedOpen Access
Longitudinal ctDNA monitoring in patients with metastatic uveal melanoma undergoing isolated hepatic perfusion in combination with ipilimumab and nivolumab
Immuno-Oncology Technology·2025Open Access
1685TiP SWE-NEO: Swedish neoadjuvant trial comparing anti-PD-1 monotherapy to combined anti-CTLA-4/anti-PD-1 blockade in resectable stage III melanoma
Annals of Oncology·2025
1678P Neoadjuvant immunotherapy for patients with resectable stage III/IV cutaneous melanoma: A Swedish retrospective real-world study (NEO-MEL)
Annals of Oncology·2025
1620P Evaluation of two dosing regimens, NIVO3+IPI1 or NIVO1+IPI3 in 399 patients with advanced melanoma
Annals of Oncology·2025
1697eP Grand SLAM: A prospective randomized international multicenter study of shortened versus standard duration adjuvant immunotherapy for stage IIb-c, III and IV cutaneous malignant melanoma (CMM)
Annals of Oncology·2025
Immune-related hepatitis and hypophysitis are associated with superior survival in melanoma patients treated with combined ipilimumab and nivolumab
OncoImmunology·2025· 2 citedOpen Access
Neoadjuvant immunotherapy for patients with resectable melanoma
British journal of surgery·2025
Magnetic seed localization in patients with nodal stage III melanoma and neoadjuvant immunotherapy, a feasibility study
British journal of surgery·2025
Management of liver metastases from uveal melanoma
British journal of surgery·2025· 3 citedOpen Access
Feasibility and outcome of genomics-guided treatment selection in advanced cancer – the MEGALiT explorative clinical trial
Acta Oncologica·2025· 1 citedOpen Access
Neoadjuvant immunotherapy for patients with resectable stage III/IV cutaneous melanoma – A Swedish retrospective real-world study (NEO-MEL)
European Journal of Cancer·2025· 6 citedOpen Access
Longitudinal ctDNA monitoring in patients with metastatic uveal melanoma undergoing isolated hepatic perfusion in combination with ipilimumab and nivolumab.
Journal of Clinical Oncology·2025
The prognostic and predictive value of the immunological gene signatures interferon gamma and TIDE for patients with liver metastases from uveal melanoma treated with isolated hepatic perfusion.
Journal of Clinical Oncology·2025
Neoadjuvant immunotherapy for patients with resectable stage III/IV cutaneous melanoma: A Swedish retrospective real-world study (NEO-MEL).
Journal of Clinical Oncology·2025
[Cell therapy with tumor infiltrating lymphocytes; a therapeutic alternative for malignant melanoma and soon also other types of cancer].
PubMed·2025
page 1 of 14Next →

Frequent Co-authors

Roger Olofsson Bagge(13), Jonas A. Nilsson(12), Henrik Jespersen(11), Karl‐Erik Andersson(11), Per Alm(9), Lisa M. Nilsson(8), Ulrika Stierner(7), Georgina V. Long(5), Max Levin(5), Per Lindnér(5), Lars Grundemar(5), Ana Arance(4), Victoria Atkinson(4), Joakim Karlsson(4), Charlotta All‐Eriksson(4), Ana Carneiro(4), Hildur Helgadóttir(4), Ingrid Ljuslinder(4), Gustav Ullenhag(4), Jan Mattsson(4)